Walgreens Boots Alliance Inc (WBA) is Burgundy Asset Management Ltd.’s Largest Position

Burgundy Asset Management Ltd. raised its position in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 5.0% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 5,441,307 shares of the pharmacy operator’s stock after buying an additional 260,756 shares during the period. Walgreens Boots Alliance accounts for about 4.0% of Burgundy Asset Management Ltd.’s investment portfolio, making the stock its biggest position. Burgundy Asset Management Ltd. owned 0.51% of Walgreens Boots Alliance worth $426,109,000 at the end of the most recent reporting period.

A number of other large investors have also recently added to or reduced their stakes in WBA. Commonwealth Bank of Australia raised its stake in shares of Walgreens Boots Alliance by 139.5% in the second quarter. Commonwealth Bank of Australia now owns 46,167 shares of the pharmacy operator’s stock worth $3,614,000 after acquiring an additional 26,893 shares during the last quarter. IBM Retirement Fund raised its stake in shares of Walgreens Boots Alliance by 88.1% in the second quarter. IBM Retirement Fund now owns 22,903 shares of the pharmacy operator’s stock worth $2,004,000 after acquiring an additional 10,729 shares during the last quarter. Andra AP fonden raised its stake in shares of Walgreens Boots Alliance by 35.3% in the second quarter. Andra AP fonden now owns 58,300 shares of the pharmacy operator’s stock worth $4,565,000 after acquiring an additional 15,200 shares during the last quarter. Schwab Charles Investment Management Inc. raised its stake in shares of Walgreens Boots Alliance by 5.4% in the second quarter. Schwab Charles Investment Management Inc. now owns 3,019,739 shares of the pharmacy operator’s stock worth $236,476,000 after acquiring an additional 154,995 shares during the last quarter. Finally, Birinyi Associates Inc. raised its stake in shares of Walgreens Boots Alliance by 9.0% in the second quarter. Birinyi Associates Inc. now owns 9,100 shares of the pharmacy operator’s stock worth $713,000 after acquiring an additional 750 shares during the last quarter. Hedge funds and other institutional investors own 60.24% of the company’s stock.

In other Walgreens Boots Alliance news, Director William C. Foote sold 2,736 shares of the company’s stock in a transaction that occurred on Thursday, November 2nd. The shares were sold at an average price of $67.37, for a total value of $184,324.32. Following the completion of the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director John Anthony Lederer bought 20,000 shares of the stock in a transaction on Thursday, October 26th. The stock was purchased at an average cost of $67.00 per share, with a total value of $1,340,000.00. Following the purchase, the director now directly owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. 14.80% of the stock is currently owned by corporate insiders.

Shares of Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $70.18 on Wednesday. The company has a debt-to-equity ratio of 0.45, a quick ratio of 0.59 and a current ratio of 1.07. The firm has a market cap of $70,879.76, a P/E ratio of 14.03, a P/E/G ratio of 1.27 and a beta of 1.22. Walgreens Boots Alliance Inc has a 12 month low of $63.82 and a 12 month high of $88.00.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 earnings per share for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. Walgreens Boots Alliance had a net margin of 3.45% and a return on equity of 18.36%. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. During the same period in the previous year, the firm posted $1.07 earnings per share. Walgreens Boots Alliance’s revenue for the quarter was up 5.3% compared to the same quarter last year. analysts predict that Walgreens Boots Alliance Inc will post 5.55 EPS for the current year.

Walgreens Boots Alliance announced that its Board of Directors has approved a stock buyback plan on Wednesday, October 25th that permits the company to repurchase $1.00 billion in shares. This repurchase authorization permits the pharmacy operator to reacquire shares of its stock through open market purchases. Shares repurchase plans are usually a sign that the company’s board believes its shares are undervalued.

The company also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be paid a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 2.28%. The ex-dividend date of this dividend is Friday, November 10th. Walgreens Boots Alliance’s payout ratio is presently 42.33%.

A number of brokerages have weighed in on WBA. Deutsche Bank began coverage on shares of Walgreens Boots Alliance in a research note on Monday. They issued a “hold” rating and a $78.00 target price for the company. Vetr downgraded shares of Walgreens Boots Alliance from a “strong-buy” rating to a “buy” rating in a research note on Friday, December 1st. Needham & Company LLC dropped their target price on shares of Walgreens Boots Alliance to $86.00 and set a “buy” rating for the company in a research note on Wednesday, November 22nd. BidaskClub raised shares of Walgreens Boots Alliance from a “strong sell” rating to a “sell” rating in a research note on Friday, November 10th. Finally, Citigroup dropped their price target on shares of Walgreens Boots Alliance from $95.00 to $81.00 and set a “buy” rating for the company in a research note on Thursday, November 2nd. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have issued a buy rating to the stock. Walgreens Boots Alliance has a consensus rating of “Buy” and an average price target of $86.47.

TRADEMARK VIOLATION NOTICE: This article was posted by Community Financial News and is the property of of Community Financial News. If you are reading this article on another site, it was illegally copied and republished in violation of U.S. and international copyright & trademark laws. The original version of this article can be viewed at https://www.com-unik.info/2017/12/06/walgreens-boots-alliance-inc-wba-is-burgundy-asset-management-ltd-s-largest-position.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Want to see what other hedge funds are holding WBA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Walgreens Boots Alliance Inc (NASDAQ:WBA).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

What are top analysts saying about Walgreens Boots Alliance Inc? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Walgreens Boots Alliance Inc and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit